BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28981193)

  • 1. Organ utilization from increased infectious risk donors: An observational study.
    L'Huillier AG; Humar A; Payne C; Kumar D
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors.
    Annambhotla PD; Gurbaxani BM; Kuehnert MJ; Basavaraju SV
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28178393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.
    Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A
    Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant Programs.
    Kumar D; Humar A; Kim SJ; Kiberd B
    Transplantation; 2016 Feb; 100(2):461-4. PubMed ID: 26285016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017.
    Abara WE; Collier MG; Moorman A; Bixler D; Jones J; Annambhotla P; Bowman J; Levi ME; Brooks JT; Basavaraju SV
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(3):61-66. PubMed ID: 30677008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue donation and virus safety: more nucleic acid amplification testing is needed.
    Pruss A; Caspari G; Krüger DH; Blümel J; Nübling CM; Gürtler L; Gerlich WH
    Transpl Infect Dis; 2010 Oct; 12(5):375-86. PubMed ID: 20412535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
    Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
    Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
    Theodoropoulos N; Kroll-Desrosiers A; Ison MG
    Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ utilization among deceased donors in Canada, 1993-2002.
    Badovinac K; Greig PD; Ross H; Doig CJ; Shemie SD
    Can J Anaesth; 2006 Aug; 53(8):838-44. PubMed ID: 16873352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased-risk versus standard-risk donation in lung transplantation: A United Network of Organ Sharing analysis.
    Brown M; Kashem MA; Zhao H; Kehara H; Yanagida R; Shigemura N; Toyoda Y
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):299-307.e3. PubMed ID: 37689235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
    Goldman JD; Pouch SM; Woolley AE; Booker SE; Jett CT; Fox C; Berry GJ; Dunn KE; Ho CS; Kittleson M; Lee DH; Levine DJ; Marboe CC; Marklin G; Razonable RR; Taimur S; Te HS; Anesi JA; Fisher CE; Sellers MT; Trindade AJ; Wood RP; Zaffiri L; Levi ME; Klassen D; Michaels MG; La Hoz RM; Danziger-Isakov L
    Transpl Infect Dis; 2023 Feb; 25(1):e14013. PubMed ID: 36694448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of Liver Transplant Candidates Toward Organs From Increased-Risk Donors.
    Humar SS; Liu J; Pinzon N; Kumar D; Bhat M; Lilly L; Selzner N
    Liver Transpl; 2019 Jun; 25(6):881-888. PubMed ID: 30947392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deceased Organ Donors With a History of Increased Risk Behavior for the Transmission of Blood-Borne Viral Infection: The UK Experience.
    Trotter PB; Summers DM; Robb M; Hulme W; Ushiro-Lumb I; Watson CJE; Neuberger J; Bradley JA
    Transplantation; 2017 Jul; 101(7):1679-1689. PubMed ID: 28291157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time.
    Baleriola C; Tu E; Johal H; Gillis J; Ison MG; Law M; Coghlan P; Rawlinson WD
    Transpl Infect Dis; 2012 Jun; 14(3):278-87. PubMed ID: 22519518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.